BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 2MAR$ who wrote (202)	11/4/1999 4:09:00 PM
From: W Shakespeare	of 253

TLC The Laser Center Inc. Announces Normal Course Issuer Bid BETHESDA, Md. and TORONTO--(BUSINESS WIRE)--Nov. 4, 1999--TLC The Laser Center Inc. (NASDAQ:TLCV) (TSE:TLC.) announced that it intends, subject to regulatory approval, to purchase up to 1.87 million of its common shares, representing approximately 5% of the 37,453,188 common shares currently outstanding. The purchases may take place from time to time, depending on market conditions, through the facilities of the Nasdaq National Market and The Toronto Stock Exchange and will commence on November 8,1999 and will terminate by November 4, 2000, or by such earlier date as TLC may determine. The prices which TLC will pay for any common shares will be the market price of the shares at the time of acquisition. Any common shares acquired by TLC will be canceled. TLC believes that currently and from time to time, the market price of its common shares may not fully reflect the value of its business and its future business prospects. In such circumstances, the purchase of TLC's outstanding shares may represent an attractive investment and an appropriate and desirable use of its available funds. TLC The Laser Center Inc. owns and manages eyecare centers throughout North America and, together with its network of eyecare providers, specializes in laser vision correction to correct common refractive vision disorders. CONTACT: Stephen Kilmer Director of Investor Relations 1-800-TLC-1033 Email: investor.relations@lzr.com Internet: tlcvision.com KEYWORD: MARYLAND INTERNATIONAL CANADA BW0285 NOV 04,1999 9:55 PACIFIC 12:55 EASTERN

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next